Articles by Daniel Marsh
AT&T Slides Again as Market Awaits Monday Test
AT&T shares fell 2.52% to $24.03 on Friday, marking a 4.5% weekly decline, as investors digest a rural coverage joint venture and FCC spectrum approval. Monday's session is seen as a key test for the stock.
Babcock & Wilcox stock offering tests rally after 50% weekly surge
Babcock & Wilcox closes $200M stock offering at $18.50 after shares surged 50% on Q1 revenue growth and AI data center demand. Investors watch for dilution impact Monday.
McCormick Shares Test Key Support Ahead of Unilever Deal Vote
McCormick shares slipped to $46.35 after touching a weekly low of $44.82, as the market awaits Monday's session to determine if the Unilever deal pressure intensifies.
NuScale Power Faces Critical Monday After Steep Weekly Decline
NuScale Power shares dropped 6.88% Friday to $11.23, capping a 10.5% weekly loss. Citi cut its target to $7 (Sell), Northland to $19 (Outperform). Q1 revenue fell sharply; net loss widened.
Natera Shares Slide Despite FDA Approval for Bladder Cancer Test
Natera shares dropped 5.36% Friday, even after the FDA approved its Signatera CDx test for use with Genentech's Tecentriq in muscle-invasive bladder cancer. The stock closed at $186.36.
Starbucks Faces Key Resistance After Announcing $400M Restructuring
Starbucks shares hover near 52-week highs after the coffee giant revealed a $400 million restructuring plan involving 300 corporate job cuts and regional office closures, part of CEO Brian Niccol's turnaround strategy.
NextEra Energy Stock Drops on $400B Dominion Merger Report
NextEra Energy shares dropped 2.42% to $93.36 Friday following a report of potential merger talks with Dominion Energy that could value the combined entity at $400 billion.
SolarEdge Surges Nearly 50% in a Week; Monday Session Could Define Trend
SolarEdge shares surged nearly 50% in a week, closing Friday at $61.76. The rally was fueled by Q1 revenue, strong Q2 guidance, and tax-credit deadline demand. Monday's session will test the breakout.
Berkshire Hathaway Reveals Macy's Stake, Stock Jumps After Hours
Berkshire Hathaway disclosed a 3 million share stake in Macy's, worth about $55 million, lifting shares 6.3% after hours. The retailer faces a tough outlook.
Berkshire Exits UnitedHealth Stake, Stock Faces Monday Pressure
Berkshire Hathaway's disclosure that it sold its UnitedHealth stake in Q1 sent shares down 1.31% to $393.85, with after-hours trading at $375.46. The stock faces Monday pressure.